1. Heart disease and stroke statistics-2021 update: a report from the American Heart Association;Virani;Circulation,2021
2. Overview of the socio-economic consequences of heart failure;Hessel;Cardiovasc Diagn Ther,2021
3. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials;Zelniker;Lancet,2019
4. US Food & Drug Administration (FDA). FDA approves treatment for wider range of patients with heart failure. Available at: https://www.fda.gov/news-events/press-announcements/fda-approves-treatment-wider-range-patients-heart-failure. Published 2022. Accessed April 11, 2022.
5. AstraZeneca. FARXIGA® (dapagliflozin) tablets, for oral use. Full prescribing information. Available at:https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202293s026lbl.pdf. Published May 2023. Accessed June 27, 2023.